Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$62K Sell
232
-1
-0.4% -$250 0.02% 234
2023
Q2
$52K Buy
233
+46
+25% +$10.7K 0.01% 260
2023
Q1
$45K Buy
187
+107
+134% +$26.3K 0.01% 272
2022
Q4
$21K Hold
80
0.01% 344
2022
Q3
$18K Hold
80
0.01% 341
2022
Q2
$19K Hold
80
0.01% 336
2022
Q1
$19K Sell
80
-2
-2% -$460 0.01% 358
2021
Q4
$18K Buy
+82
New +$17.3K 0.01% 376
2021
Q3
Sell
-80
Closed -$20K 187
2021
Q2
$20K Sell
80
-61
-43% -$15K 0.01% 347
2021
Q1
$35K Buy
+141
New +$33.6K 0.01% 301

Other funds holding AMGN

KB Financial Partners's AMGN Position: Q3 2023 in Review

KB Financial Partners reduced its Amgen (AMGN) stake by 0.43% in Q3 2023, selling an estimated $250 and leaving 232 shares worth $62K. The position accounts for 0.02% of the portfolio, ranked #234.

KB Financial Partners first reported a position in AMGN in Q1 2021 and has held it in 10 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • KB Financial Partners held 232 shares of Amgen worth $62K as of Q3 2023.
  • KB Financial Partners sold 1 Amgen share in Q3 2023, an estimated $250.
  • Amgen made up 0.02% of KB Financial Partners's portfolio in Q3 2023, its #234 holding.
  • KB Financial Partners first reported a position in Amgen in Q1 2021 and has held it in 10 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.